Genome-wide CRISPR-Cas 9 screens identify BCL family members as modulators of response to regorafenib in experimental glioma.
Haeusser LA, Becker H, Kuhlburger L, Zago M, Walter B, Tsiami F, Erdmann S, Trampert J, Surender S, Stahl A, Templin M, Wegner E, Schmidt T, Schmees C, Casadei N, Sevenich L, Claassen M, Nahnsen S, Beck S, Merk DJ, Tabatabai G.
Haeusser LA, et al. Among authors: beck s.
Neuro Oncol. 2025 Jan 4:noae278. doi: 10.1093/neuonc/noae278. Online ahead of print.
Neuro Oncol. 2025.
PMID: 39756423